EGeen International Inc.   Report issue

For profit Phase 3
Founded: Milpitas CA United States (2001)

Organization Overview

First Clinical Trial
2015
NCT02913521
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now